Clinical Trial Search
Colorectal Cancer
-
BP25438
A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer Recruiting -
GO28074
A Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI in Second Line in Patients With KRAS Wild-Type Metastatic Colorectal Cancer Recruiting -
ML25198
An Observational Study of Avastin (Bevacizumab) in Patients With Colorectal Cancer Recruiting -
ML25391
An Observational Study of Avastin (Bevacizumab) in Combination With 5-FU-Based Chemotherapy as First-Line Treatment in Chinese Patients With Metastatic Colorectal Cancer Recruiting -
ML25526
An Observational Study of Adjuvant Treatment with Xeloda (Capecitabine) in Combination with Oxaliplatin in Patients with Stage III Colon Cancer Recruiting -
ML25625
A Study of Avastin (Bevacizumab) and FOLFOX in Patients With Colorectal Cancer Recruiting -
ML25710
Study of Bevacizumab/mFOLFOX6 versus Bevacizumab/Folfiri with Biomarker Stratification in Patients with Previously Untreated Metastatic Colorectal Cancer Recruiting -
ML25753
A Translational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ASCENT) Recruiting -
ML27768
An Observational Study of Avastin and Conventional Chemotherapy in Patients >/= 70 Years of Age With Previously Untreated Metastatic Colorectal Cancer (AVAPLUS) Recruiting -
ML27791
AXEL Study: An Observational Study of First-Line Xeloda (Capecitabine) Based Chemotherapy With or Without Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer Recruiting -
ML27829
An Observational Study of Avastin in First Line in Elderly Patients With Metastatic Colorectal Cancer (CASSIOPEE) Recruiting -
ML27907
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer in Italy (BEWARE) Recruiting -
ML27971
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN) Recruiting -
ML28120
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (Koralle) Recruiting -
ML28233
An Observational Study of Avastin (Bevacizumab) With First-Line Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer Recruiting -
ML28411
An Observational Study of Avastin (Bevacizumab) in Patients with Metastatic Cancer of the Colon or Rectum Recruiting -
ML28419
A Study of Avastin (Bevacizumab) in Combination With 5-FU Based Doublet Chemotherapy in Patients With Colorectal Cancer And Previously Untreated Unresectable Liver-Only Metastases Recruiting -
ML28442
STEAM: A Study of Sequential and Concurrent FOLFOXIRI/Avastin (Bevacizumab) Regimens Versus FOLFOX/Avastin in First-Line in Patients With Metastatic Colorectal Cancer Recruiting -
ML28579
A Non-Interventional Study of the Occurrence Rate of Colon, Breast and Gastric Cancer and Malignant Melanoma in Turkey and Diagnosis and Treatment Characteristics Recruiting -
BO20696
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer. Completed -
BP22909
A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer Completed -
BP27931
A Study of Capecitabine Rapid Disintegrating Tablets (RDT) Versus Commercial Xeloda in Patients with Solid Tumours Completed -
M66001
A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer Completed -
M66007
SOCRATES Study - A Study of Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer Completed -
M66011
A Study of Xeloda (Capecitabine) Plus Radiotherapy in Patients With Rectal Cancer Completed -
M66020
A Study of the Efficacy and Tolerability of Xeloda (Capecitabine) in First-Line and Second-Line Therapy in Patients With Metastatic Colorectal Cancer Completed -
M66051
A Study of Xeloda (Capecitabine) Combined With Standard Radiotherapy in Patients With Locally Advanced Rectal Cancer Completed -
ML16987
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer Completed -
ML18017
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer Completed -
ML18280
A Study of Xeloda (Capecitabine) in Combination Chemotherapy With Eloxatin (Oxaliplatin) Plus Pelvic Irradiation Before Surgery for Rectal Cancer Completed -
ML18436
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Completed -
ML18491
A Study of Two Different Schedules of Xeloda (Capecitabine) as First Line Therapy in Patients With Metastatic Colorectal Cancer Completed -
ML18522
A Study of Avastin (Bevacizumab) Plus Xeloda (Capecitabine) in Patients With Locally Advanced Rectal Cancer. Completed -
ML18523
A Study of Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer. Completed -
ML18524
A Study of Avastin (Bevacizumab) in Combination Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Completed -
ML18559
A Study of Avastin (Bevacizumab) Combined With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Completed -
ML18601
A Study of Xeloda (Capecitabine) in the Adjuvant Treatment of Patients With Resected Colon Cancer Completed -
ML19875
A Study of Avastin (Bevacizumab) in Combination With Xelox and Tarceva in Patients With Metastatic Colorectal Cancer. Completed -
ML20552
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum. Completed -
ML20592
A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. Completed -
ML21209
A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Colorectal Cancer Completed -
ML21380
OBELIX Study: A Study of Avastin (Bevacizumab) in Combination With XELOX in Patients With Metastatic Cancer of the Colon or Rectum. Completed -
ML21440
A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) as Maintenance Treatment in Patients With Metastatic Colorectal Cancer. Completed -
ML21800
A Study of Xeloda (Capecitabine) plus Radiotherapy in Patients With Locally Advanced Rectal Cancer Completed -
ML21875
An Observational Study of Xeloda (Capecitabine) and Oxaliplatin Prior and Concurrent To Preoperative Pelvic Radiotherapy in Patients With Locally Advanced Rectal Cancer Completed -
ML22399
An Observational Study of Avastin (Bevacizumab) in First Line in Patients With Metastatic Colorectal Cancer (AVANiS) Completed -
ML22519
A Study of Avastin (Bevacizumab) With XELOX in Patients With Colorectal Cancer and Disease Progression on FOLFIRI and Avastin Completed -
ML25281
An Observational Study of Xeloda (Capecitabine) in Patients with Metastatic Colorectal Cancer, Colon Cancer in the Adjuvant Setting, Advanced Gastric Cancer or Breast Cancer Completed -
ML25630
BEVERLY-C: An Observational Study of Avastin (Bevacizumab) in First-Line Treatment in Elderly Patients With Metastatic Colorectal Cancer Completed -
MO16460
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer Completed -
MO16461
A Study of Xeloda (Capecitabine) in Patients With Advanced and/or Metastatic Colorectal Cancer Completed -
MO17654
A Dose-Finding Study of Tarceva (Erlotinib) in Combination Chemotherapy for Metastatic Colorectal Cancer. Completed -
MO18024
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Completed -
MO18458
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Metastatic Cancer of the Colon or Rectum Completed -
MO19286
A Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) in Elderly Patients With Metastatic Colorectal Cancer. Completed -
NO16966
A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer Completed -
NO16967
A Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer Completed -
NO16968
A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer Completed -
NO20254
A Study of Avastin (Bevacizumab) in Combination With XELOX or FOLFOX-4 in Patients With Metastatic Colorectal Cancer. Completed -
NP18587
A Study of Xeloda (Capecitabine) in Combination With Oxaliplatin in Patients With Metastatic Colorectal Cancer. Completed -
ML21567
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer. Terminated -
BO17920
A Study of Avastin (Bevacizumab) Added to Various Chemotherapy Regimens in Patients With Colon Cancer Active, not recruiting -
GO27827
FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer Active, not recruiting -
ML18147
A Study of Avastin (Bevacizumab) Plus Crossover Fluoropyrimidine-Based Chemotherapy in Patients With Metastatic Colorectal Cancer. Active, not recruiting -
ML19202
A Study of Avastin (Bevacizumab) in Patients With Newly Diagnosed Locally Advanced Rectal Cancer. Active, not recruiting -
ML20452
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. Withdrawn -
ML20514
OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer Active, not recruiting -
ML21889
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (RELEVANT) Active, not recruiting -
ML22585
An Observational Study of Xeloda (Capecitabine) in Patients With Metastatic Colorectal Cancer (AXIOM) Active, not recruiting -
ML22999
An Observational Study on Avastin (Bevacizumab) as First-Line Treatment in Colorectal Cancer Patients With Potentially Resectable Liver Metastases (PICASSO) Active, not recruiting -
ML25117
Observational Study of Bevacizumab [Avastin] in Patients with Metastatic Colorectal Cancer (AVASTART) Active, not recruiting -
ML25174
An Observational Study of Xeloda (Capecitabine) Monotherapy in Patients With Colorectal Cancer (AXEL) Active, not recruiting -
ML25178
An Observational Study on The Correlation Between Time of Initiation of Avastin (Bevacizumab) Treatment And Progression-Free Survival in Patients With Colorectal Cancer (CRONOS 1) Active, not recruiting -
ML25523
An Observational Study of Avastin (Bevacizumab) in Combination With Xeloda (Capecitabine) And Oxaliplatin in Patients With Colorectal Cancer Active, not recruiting -
ML25686
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX6 in Treatment-Naïve Patients With Metastatic Colorectal Cancer With or Without K-RAS Mutations, and Comparison to Cetuximab Withdrawn -
MO18725
A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer. Active, not recruiting -
NP25247
A Study of RO5212054 (PLX3603) in Patients With BRAF V600-mutated Advanced Solid Tumours Active, not recruiting